These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27729025)

  • 1. Survival outcomes for first-line antiretroviral therapy in India's ART program.
    Dandona R; Rewari BB; Kumar GA; Tanwar S; Kumar SG; Vishnumolakala VS; Duber HC; Gakidou E; Dandona L
    BMC Infect Dis; 2016 Oct; 16(1):555. PubMed ID: 27729025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
    Ayele W; Mulugeta A; Desta A; Rabito FA
    BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of immunological failure and determinants of suboptimal CD4 testing among adults with HIV on first-line antiretroviral therapy in Andhra Pradesh, India, 2008-2011.
    Allam RR; Murhekar MV; Bhatnagar T; Uthappa CK; Nalini C; Rewari BB; Mehendale SM
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):325-33. PubMed ID: 25778736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008-2011.
    Allam RR; Murhekar MV; Bhatnagar T; Uthappa CK; Chava N; Rewari BB; Venkatesh S; Mehendale S
    Trans R Soc Trop Med Hyg; 2014 Apr; 108(4):198-205. PubMed ID: 24627424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling adverse treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics in Lusaka.
    Fwemba I; Musonda P
    Public Health; 2017 Jun; 147():8-14. PubMed ID: 28404502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How varying CD4 criteria for treatment initiation was associated with mortality of HIV-patients? A retrospective analysis of electronic health records from Andhra Pradesh, India.
    Bajpai R; Chaturvedi HK; Car J
    J Glob Health; 2020 Jun; 10(1):010408. PubMed ID: 32257156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
    Mugisha V; Teasdale CA; Wang C; Lahuerta M; Nuwagaba-Biribonwoha H; Tayebwa E; Ingabire E; Ingabire P; Sahabo R; Twyman P; Abrams EJ;
    PLoS One; 2014; 9(1):e85774. PubMed ID: 24454931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
    Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
    Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013.
    Bajpai R; Chaturvedi H; Jayaseelan L; Harvey P; Seguy N; Chavan L; Raj P; Pandey A
    J Prev Med Public Health; 2016 Nov; 49(6):394-405. PubMed ID: 27951632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.
    Bachani D; Garg R; Rewari BB; Hegg L; Rajasekaran S; Deshpande A; Emmanuel KV; Chan P; Rao KS
    Natl Med J India; 2010; 23(1):7-12. PubMed ID: 20839585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes.
    Nuwagaba-Biribonwoha H; Jakubowski A; Mugisha V; Basinga P; Asiimwe A; Nash D; Elul B
    BMC Public Health; 2014 Aug; 14():889. PubMed ID: 25168699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011.
    Bhatta L; Klouman E; Deuba K; Shrestha R; Karki DK; Ekstrom AM; Ahmed LA
    BMC Infect Dis; 2013 Dec; 13():604. PubMed ID: 24369908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.
    Castelnuovo B; Musaazi J; Musomba R; Ratanshi RP; Kiragga AN
    BMC Infect Dis; 2015 Jul; 15():252. PubMed ID: 26126616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.